US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

100.82

-0.7111-0.70%

Volume:355.46K

Turnover:35.83M

Market Cap:1.61B

PE:9.39

High:101.91

Open:101.91

Low:100.34

Close:101.53

52wk High:108.66

52wk Low:69.02

Shares:16.00M

Float Shares:16.00M

Volume Ratio:4.70

T/O Rate:2.22%

Dividend:1.47

Dividend Rate:1.45%

EPS(TTM):10.74

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

Royalty Pharma Down Nearly 6%, on Pace for Largest Percent Decrease Since March 2025

Royalty Pharma Falls After Novartis' Cholesterol Drug Fails in Study

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints

MT Newswires Live

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS

Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies

THOMSON REUTERS

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

Jeito Capital Promotes Pascal Touchon to Partner

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/IHE/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IHE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","market":"US","secType":"STK","nameCN":"iShares U.S. Pharmaceuticals ETF","latestPrice":100.82,"timestamp":1789491750222,"preClose":101.53112,"halted":0,"volume":355461,"delay":0,"changeRate":-0.007003960953055656,"floatShares":16000000,"shares":16000000,"eps":10.735807,"marketStatus":"Trading","change":-0.71112,"latestTime":"09-15 13:03:48 EDT","open":101.91,"high":101.91,"low":100.34,"amount":35833225.400055,"amplitude":0.015463,"askPrice":100.83,"askSize":110,"bidPrice":100.72,"bidSize":110,"shortable":3,"etf":1,"ttmEps":10.735807,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.53112,"sharesOutstanding":11650000,"nav":101.095472,"aum":1617527552,"dividendRate":0.014536,"bidAskSpread":0.000692,"preHourTrading":{"tag":"盘前","latestPrice":101.78,"preClose":101.53112,"latestTime":"08:05 EDT","volume":2,"amount":203.56,"timestamp":1789473923900,"change":0.24888,"changeRate":0.002451,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":101.81,"preClose":101.81,"latestTime":"19:43 EDT","volume":120,"amount":12225.2,"timestamp":1789429405230,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":4.697504,"impliedVol":0.1736,"impliedVolPercentile":0.9522},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","floatShares":16000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.697504,"shares":16000000,"dividePrice":1.4655,"high":101.91,"amplitude":0.015463,"preClose":101.53112,"low":100.34,"week52Low":69.02,"pbRate":"--","week52High":108.66,"institutionHeld":0,"latestPrice":100.82,"eps":10.735807,"divideRate":0.014536,"volume":355461,"delay":0,"ttmEps":10.735807,"open":101.91,"prevYearClose":84.83,"prevWeekClose":101.07,"prevMonthClose":103.64,"prevQuarterClose":99.01,"fiveDayClose":102.68,"twentyDayClose":103.08,"sixtyDayClose":91.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IHE\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IHE","amount":0.278883,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IHE","amount":0.284781,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IHE","amount":0.284491,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IHE","amount":0.585254,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IHE","amount":0.312397,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IHE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.315888,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.33773,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.358233,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.91844,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.449501,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IHE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IHE\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666104377","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666104377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666104377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:33","pubTimestamp":1788899580,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.24% to $148.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 5.39% short of its 52-week high of $156.92, which the company reached on August 25th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Eli Lilly & Co.  fell 2.21% to $1,123.91.Trading volume  eclipsed its 50-day average volume of 9.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","FHLC","LU1116320737.USD","BK4516","LU2433249047.HKD","XLV","LU0265550946.USD","LU1989772840.SGD","LU0130517989.USD","LU2125909247.SGD","IE00B1BXHZ80.USD","LU0985320562.USD","IXJ","BK4533","GDOC","BK4559","LU0942090050.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1035773651.USD","JDOC","LU0106261372.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0124676726.USD","LU1093756168.USD","LU2491050071.SGD","SG9999013999.USD","LU1201861249.SGD","LU0965509101.SGD","IE000M9KFDE8.USD","LU0203345920.USD","RXL","LU1162221912.USD","LU1066051225.USD","LU0289739699.SGD","BK4585","LU2361044865.SGD","VHT","LU2023250504.SGD","LU0208291251.USD","LU2468319806.SGD","LU2491050154.USD","BK4588","LU0432979614.USD","LU0122379950.USD","LU0266013472.USD","LU0320765646.SGD","LU0868494617.USD","IE00BLSP4452.SGD","LU1934455863.HKD","LU1989772923.USD","MRK","LU0006306889.USD","SG9999014575.USD","LU2491049909.HKD","LU1934455194.USD","SG9999014542.SGD","SG9999002224.SGD","LU1116320901.HKD","SG9999014567.USD","LU2125909593.SGD","LU2461242641.AUD","LU1941712264.USD","LU1585245621.USD","LU1571399168.USD","IE00BBT3K403.USD","BK4534","SG9999001440.SGD","SG9999002232.USD","LU1032466523.USD","LU2361045086.USD","IE00BSNM7G36.USD","LU1061106388.HKD","LU1989771016.USD","BK4550","LU1023059063.AUD","LU1917777945.USD","LU1291159041.SGD","SG9999015358.SGD","LU1066051811.HKD","LU0980610538.SGD","LU0868494708.USD","FTXH","IE0002141913.USD","LU0070302665.USD","IE00BN8TJ469.HKD","LU1934455277.USD","LU0320765489.SGD","LU0965508806.USD","BK4007","LU0234572021.USD","LU2112291526.USD","LU0098860793.USD","LU1941712348.USD","IHE","LU2125154778.USD","LU1430594728.SGD","LU2106854487.HKD","IYH","LU1923622614.USD","SG9999001176.SGD","LU1066051498.USD","LU0265550359.USD","LU0058720904.USD","LU2361044949.HKD","LU1983299246.USD","HRTS","LU1069347547.HKD","SG9999014559.SGD","IE0009355771.USD","LU2089984988.USD","PAWZ","LU0203347892.USD","IE00BLSP4239.USD","LU1037948897.HKD","SGXZ57979304.SGD","LU0477156953.USD","LU0859254822.USD","LU0861579265.USD","LU2023250843.SGD","LU0648001328.SGD","LU2125154935.USD","LU0689626769.HKD","LU0130102774.USD","BMED","LU0823416689.USD","IE00BJT1NW94.SGD","LU0238689110.USD","LU1929549753.HKD","TRUH","IE00B4R5TH58.HKD","LU2357627491.SGD","LU0965509283.SGD","SG9999015341.SGD","IE00B2B36J28.USD","LU2360032135.SGD","LU1093756325.SGD","LU1974910355.USD","LU0965509010.AUD","LU1699723380.USD","LU1066053197.SGD","PPH","LU1057294990.SGD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666031372","title":"Protagonist Therapeutics Launches USD 300 Million Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics launches USD 300 million share buyback programProtagonist Therapeutics launched a share repurchase program for up to USD 300 million of outstanding common stock.Funding planne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc74SRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","SGXZ80539844.SGD","IE0009355771.USD","PTGX","BK4007","LU0058720904.USD","JNJ","LU1057294990.SGD","IE0002141913.USD","TRUH","LU0689472784.USD","GDOC","LU1506573853.SGD","PJP","IYH","IE00B4R5TH58.HKD","LU2468319806.SGD","IE00B42XCP33.USD","LU0820562030.AUD","IE00BGHQF631.EUR","IE00BFXG1179.USD","LU2487616109.SGD","MEDX","LU1267930813.SGD","LU1718418525.SGD","LU2430703095.HKD","SG9999001440.SGD","LU1032955483.USD","LU0683600562.USD","IE00B19Z3B42.SGD","JDOC","FHLC","LU1244550221.USD","LU1551013342.USD","BK4504","LU1778281490.HKD","IE00BDGV0183.EUR","LU2750360641.GBP","VHT","LU2602419157.SGD","BK4588","BMED","IHE","XLV","LU1066051225.USD","RXL","BK4533","SG9999001176.SGD","LU1145028129.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666914372","title":"Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666914372","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666914372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:15","pubTimestamp":1788894935,"startTime":"0","endTime":"0","summary":"• Bristol-Myers Squibb faced profit-taking despite positive Phase 2 trial results for arlocabtagene autoleucel.\n• Investors reacted cautiously due to unspecified regulatory timelines and recent clinical trial enrollment pauses.\n• The company reports $48.19B in annual revenue and maintains solid financial operating metrics.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156735-market-movers-bmy-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU1261432733.SGD","LU1983299246.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1868836591.USD","BK4559","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU0306807586.USD","IHE","BK4534","IE0002141913.USD","LU0267386448.USD","LU0432979614.USD","BK4007","LU0456855351.SGD","LU1868836757.USD","LU1868837136.USD","BK4532","LU2242652126.USD","LU1074936037.SGD","LU0225284248.USD","LU1291159041.SGD","LU1236620750.USD","LU2125154935.USD","LU2360032135.SGD","LU1093756168.USD","BK4585","LU1670710588.SGD","LU2125154778.USD","LU2242646821.SGD","LU1430594728.SGD","LU1868836914.USD","IE00BSNM7G36.USD","LU0096364046.USD","LU0882574055.USD","LU1670711040.USD","IE0009355771.USD","BMY","IE00B2B36J28.USD","LU2596442595.SGD","IE00BFXG1179.USD","LU1670710661.SGD","LU0985481810.HKD","LU0868494617.USD","LU0114720955.EUR","LU1323610961.USD","LU1718418525.SGD","LU0225771236.USD","FTXH","LU0237698245.USD","LU1093756325.SGD","LU0306806265.USD","LU1571399168.USD","BK4588","LU0061475181.USD","BK4581","LU1032466523.USD","LU1236620834.HKD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU1989771016.USD","LU1883839398.USD","LU1670711123.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823434740.USD","HRTS","ELIL","LU0787776722.HKD","LU0097036916.USD","LU2236285917.USD","IE0004445239.USD","CURE","LU0266013472.USD","FHLC","IE00B1XK9C88.USD","LLYX","LU1629891620.HKD","LU2471134879.HKD","LU2461242641.AUD","LU2602419157.SGD","LU0316494557.USD","AGNG","LU2552382215.SGD","SG9999015986.USD","LU2237443382.USD","LU1720051017.SGD","LU0882574139.USD","SG9999015978.USD","LU0210536198.USD","LU1548497426.USD","IE00BJJMRX11.SGD","LU2361044949.HKD","VHT","BK4516","SGXZ31699556.SGD","IE00BJT1NW94.SGD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0683600562.USD","LU2456880835.USD","LU2237443978.SGD","LU0786609619.USD","IE00BKPKM429.USD","LU1366192091.USD","LU2211815571.USD","LU1804176565.USD","IE00BN29S564.USD","LU2108987350.USD","PPH","LU0471298777.SGD","LU0889565916.HKD","LU0354030511.USD","IE00BK4W5L77.USD","LU2746668461.USD","IYH","LU0689472784.USD","LU1127390331.HKD","LU1917777945.USD","LU2237438978.USD","LU2552382058.USD","LU1868836591.USD","LU1691799644.USD","SG9999013999.USD","WDNA","LU2023250330.USD","IE00BFTCPJ56.SGD","LU0345770993.USD","SG9999015945.SGD","LU1814569148.SGD","LU2360106947.USD","LU0061475181.USD","BK4533","ILDR","LU2271345857.HKD","LU1267930730.SGD","LU0672654240.SGD","LU0385154629.USD","LU1093756325.SGD","LU1232071149.USD","LU2750360997.AUD","IXJ","LU0079474960.USD","IE00BJJMRY28.SGD","LU0320765059.SGD","LU1023059063.AUD","LU0114720955.EUR","LU2756315318.SGD","CANC","LU2237443622.USD","IE00BJLML261.HKD","LU2168564065.EUR","LU1868837300.USD","LU0820561818.USD","SG9999001176.SGD","BK4599","LU2552382132.HKD","IHE","LU0708995401.HKD","LU1280957306.USD","LU2756315664.SGD","LU0106261372.USD","LU2361045086.USD","LU2237443549.SGD","LU2265009873.SGD","LU0174119429.USD","LU0466842654.USD","LU0256863902.USD","LU0640476718.USD","LU0417517546.SGD","SGXZ51526630.SGD","LU0353189763.USD","LU1061106388.HKD","LU1145028129.USD","LLYZ","LU2168564222.USD","LU2264538146.SGD","LU0882574055.USD","LU2746668974.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2168564149.EUR","LU2168564495.EUR","LLII","LU2471134796.USD","LU1323610961.USD","LU0323591593.USD","LU1064131342.USD","LU2462591350.SGD","LU0820562030.AUD","LU0456855351.SGD","MEDX","GDOC","LU1868836914.USD","LU1551013425.SGD","LU0198837287.USD","IE00B4JS1V06.HKD","LU0158827781.USD","SGXZ81514606.USD","LU2471134523.USD","LU2089284900.SGD","SG9999018865.SGD","LU0006306889.USD","LU0353189680.USD","LU0354030438.USD","GB00BDT5M118.USD","LU0203202063.USD","LU1868836757.USD","FTXH","LU1057294990.SGD","LU0058720904.USD","LU2361044865.SGD","LU2471134952.CNY","SG9999014914.USD","SG9999017495.SGD","IE00BKDWB100.SGD","LU1983299246.USD","SG9999014898.SGD","SG9999018857.SGD","LU1988902786.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1035775433.USD","LU2417539215.USD","LU2357305700.SGD","LU2087625088.SGD","LU2237443465.HKD","LU2750360641.GBP","LU1623119135.USD","BK4581","BK4588","LU2028103732.USD","BK4007","IE0005OL40V9.USD","LU2468319806.SGD","SGXZ57979304.SGD","RXL","LU0345770308.USD","OZEM","BK4534","IE00B2B36J28.USD","TRUH","LU0238689110.USD","LU2023250504.SGD","LU0471298694.HKD","LU0203201768.USD","LU2023251221.USD","LU2111349929.HKD","LU2462157665.USD","MHIP","LU0256863811.USD","LU1093756168.USD","IE00BFSS7M15.SGD","LU1979441026.SGD","BK4585","LU2063271972.USD","LU2491050154.USD","SG9999014906.USD","LU0133085943.USD","THNR","LU1712237335.SGD","SG9999014880.SGD","LU1069344957.HKD","IE0002141913.USD","ELIS","LU2896262040.SGD","LU0225283273.USD","LU0964807845.USD","LU0820561909.HKD","LU0289739699.SGD","SGXZ99366536.SGD","XLV","IE00BJJMRZ35.SGD","LU2112291526.USD","SG9999015952.SGD","LU2168563687.JPY","LU0320765992.SGD","LU0096364046.USD","LU0094547139.USD","LU1551013342.USD","LU2324357040.USD","LU0943347566.SGD","LU0823434583.USD","LU0109391861.USD","MEDI","SG9999001176.USD","LU1291159041.SGD","IE00BWXC8680.SGD","IE0009355771.USD","LU0234572021.USD","LU0158827948.USD","LU1720051108.HKD","LU2237443895.HKD","LU1989771016.USD","IE00BK4W5M84.HKD","TMED","LU0109394709.USD","LU2089984988.USD","JDOC","LU0432979614.USD","LU2213496289.HKD","LU2491050071.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","PJP","LU0122379950.USD","LLY","LU2491049909.HKD","IE0004445015.USD","LU1868837136.USD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372374","title":"Royalty Pharma Down Nearly 6%, on Pace for Largest Percent Decrease Since March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372374?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:26","pubTimestamp":1788888360,"startTime":"0","endTime":"0","summary":"Royalty Pharma Plc Class A  is currently at $60.20, down $3.76 or 5.88%--Would be lowest close since Aug. 18, 2026, when it closed at $59.69--On pace for largest percent decrease since March 26, 2025, when it fell 6.52%--Snaps a five-day winning streak--Down 1.97% month-to-date--Up 55.8% year-to-date--Down 5.88% from its all-time closing high of $63.96 on Sept. 4, 2026--Up 64.93% from 52 weeks ago , when it closed at $36.50--Down 5.88% from its 52-week closing high of $63.96 on Sept. 4, 2026--Up 72.49% from its 52-week closing low of $34.90 on Sept. 25, 2025--Traded as low as $58.63; lowest intraday level since Aug. 17, 2026, when it hit $58.18--Down 8.33% at today's intraday low; largest intraday percent decrease since June 19, 2020, when it fell as much as 8.53%All data as of 1:22:25 PM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","PBE","RPRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666737149","title":"Royalty Pharma Falls After Novartis' Cholesterol Drug Fails in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666737149","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666737149?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:40","pubTimestamp":1788885632,"startTime":"0","endTime":"0","summary":"BUZZ-Royalty Pharma falls after Novartis' cholesterol drug fails in study** Shares of Royalty PharmaRPRX.Ofall 6% to $60.14 in afternoon trade** RPRX buys royalties of future drugs from academic labs and biotechs** Swiss drugmaker Novartis'NOVN.Scholesterol drug pelacarsenfailsin a closely watched study** RPRX says its $500 million funding agreement with NOVN's partner IonisIONS.Owas structured to limit risk with stable and predictable royalties in another drug Spinraza and potential gains from pelacarsen** RPRX expects to recoup its total investment and earn a modest positive return despite pelacarsen's failure**  \"We had previously estimated combined 2032 end-market sales of $1.6B  and royalties of $80MM . A missed opportunity, but the growth outlook is little changed\" - Royalty Pharma** RPRX reiterates \"its 2030 Portfolio Receipts target of $4.7 billion or more\"** Including session's move, stock up 54.7% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4501D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0289739699.SGD","LU2468319806.SGD","LU0868494617.USD","BK4534","LU2089984988.USD","IE0002141913.USD","IE0009355771.USD","LU2112291526.USD","PJP","IE00BFTCPJ56.SGD","BK4599","LU1061106388.HKD","RPRX","IE00BJT1NW94.SGD","BBH","LU0320765992.SGD","TBXU","SG9999001440.SGD","LU2242646821.SGD","BK4581","LU1983299246.USD","BK4585","IBB","BK4139","IBBQ","BK4533","LU0889565916.HKD","IE00BJJMRZ35.SGD","IONS","LU1023059063.AUD","LU1057294990.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","BK4007","BK4566","LU0122379950.USD","IHE","PBE","BIB","AMGN","LU1571399168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665754593","title":"Dow Drops 438 Points on Losses for Amgen, Salesforce Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665754593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665754593?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:45","pubTimestamp":1788875100,"startTime":"0","endTime":"0","summary":"DJ Dow Drops 438 Points On Losses For Amgen, Salesforce SharesThis article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is declining Tuesday morning with shares of Amgen and Salesforce seeing the biggest declines for the blue-chip average.Shares of Amgen  and Salesforce  are contributing to the index's intraday decline, as the Dow  was most recently trading 438 points, or 0.8%, lower.Amgen's shares have declined $30.47, or 7.0%, while those of Salesforce have fallen $11.09, or 4.3%, combining for a roughly 247-point drag on the Dow.Also contributing significantly to the decline are Johnson & Johnson , IBM , and Microsoft .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","IE000F7OJYX1.SGD","LU2095319765.USD","LU0757359954.USD","LU0211331839.USD","LU1069344957.HKD","LU2471134952.CNY","LU1267930813.SGD","BMED","IE0004086264.USD","LU2097829019.USD","XLI","BK4577","LU2097344357.USD","IE00BJTD4N35.SGD","LU2125909247.SGD","SGXZ51526630.SGD","LU2168564222.USD","LU2357305700.SGD","IE0034235303.USD","LU1236620750.USD","LU2506951958.HKD","LU0724617625.USD","HK0000819398.USD","LU1791710582.SGD","LU0251131958.USD","LU1674673691.USD","LU0820561818.USD","LU1935043536.SGD","IE00BHPRN162.USD","LU1037948541.HKD","IE0000B7K699.USD","LU2089984988.USD","LU0006306889.USD","LU1301847155.USD","IE0034235188.USD","HK0000304797.USD","LU1228905037.USD","LU0210528500.USD","LU2487616109.SGD","LU2420271590.USD","LU1235294995.USD","LU1989773731.SGD","NULC","LU1814569148.SGD","OGIG","LU0965509010.AUD","LU1983299246.USD","IE00BKVL7J92.USD","LU0130518102.USD","LU2461242641.AUD","LU2462157665.USD","LU0289739343.SGD","BK4538","LU2063271972.USD","LU2404859741.USD","IE00BYQQ9H92.USD","LU0187121727.USD","LU0289961442.SGD","LU2168564495.EUR","LU0130103400.USD","LU2041044095.USD","LU2361044865.SGD","CRM","IE00B19Z8W00.USD","LU0757359368.USD","LU0070217475.USD","IE00B3T34201.USD","LU2456880835.USD","CNEQ","LU1043141123.HKD","IE00B1BXHZ80.USD","IE0009G5SDU7.USD","LU0097036916.USD","LU0314104364.USD","LU1582987597.SGD","LU0353189680.USD","LU1069347547.HKD","IE0002270589.USD","LU0061474960.USD","LU1116320737.USD","LU0690374615.EUR","LU1868836591.USD","LU1923622614.USD","IBX","LU0912757837.SGD","LU2092627202.USD","SG9999002232.USD","LU0128525929.USD","LU0174119429.USD","BK4535","CMAG","IE00BQXX3F31.USD","LU1670711123.USD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","FDN","LU2077746001.SGD","LU2148611432.USD","XLK","LU1934455194.USD","IE00BLSP4239.USD","LU1235295455.SGD","IBM","LU1188199696.SGD","SG9999015978.USD","SNPE","LU2129689431.USD","IE00BJT1NW94.SGD","LU0094547139.USD","LU1043141396.HKD","BK4567","LU0081259029.USD","LU0640476718.USD","LU1979441026.SGD","LU0198837287.USD","LU1934455863.HKD","LU1046421795.USD","LU2087625088.SGD","LU0823417737.USD","IE00B7KXQ091.USD","LU0251132253.USD","HK0000304805.HKD","LU1670628061.USD","IE00BJLML261.HKD","LU2357627491.SGD","LU0158827781.USD","FHLC","LU0784383803.USD","IE00BDGV0183.EUR","LU0784384876.USD","PBE","LU0353189763.USD","LU0528227936.USD","MEDX","ROM","LU0061474705.USD","BK4607","BK4527","LU1064131342.USD","LU1803068979.SGD","LU1868836757.USD","LU0957791311.USD","IE00B42XCP33.USD","LU2023250330.USD","SG9999001176.SGD","LU2506951875.HKD","LU1868836914.USD","BK4525","LU2720916845.USD","IE00B19Z8X17.USD","LU1323610961.USD","IE0004445015.USD","LU0472753341.HKD","LU2417539215.USD","LU0208291251.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","SG9999004303.SGD","IE00BFXG1179.USD","BK4533","LU0048573561.USD","LU1430594728.SGD","LU1645745479.HKD","LU0096362180.USD","LU2552382132.HKD","LU2168564149.EUR","LU2237438978.USD","IE0034235295.USD","LU1670711040.USD","IE00BMPRXR70.SGD","LU2746668461.USD","LU0143551892.USD","LU1894683348.USD","LU0879622024.SGD","LU2750360641.GBP","LU0342679015.USD","IE00BQXX3D17.EUR","LU2458330169.SGD","BK4503","LU0553294199.USD","IE00B19Z3581.USD","LU1035775433.USD","BK4599","IE000MB6IJN5.SGD","LU1196500208.SGD","LU1244550494.USD","LU0256863902.USD","LU2250418816.HKD","LU0820562030.AUD","LU1951200564.SGD","LU0312595415.SGD","LU0345769128.USD","LU1880398554.USD","LU1153585028.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","XLV","IE0004091025.USD","DGRO","MYMmain","LU1035773651.USD","SGXZ99366536.SGD","EFIV","LU1670710588.SGD","LU2381873111.SGD","LU1988902786.USD","LU1974910355.USD","VUG","LU2491049909.HKD","IE00BN8TJ469.HKD","LU2242652126.USD","SDOW","LU2236285917.USD","LU0109391861.USD","IE00B4JS1V06.HKD","LU0354030438.USD","LU1582986433.USD","SG9999014575.USD","DXD","LU1642822529.SGD","SG9999001077.SGD","IE00B2B36J28.USD","LU2756315664.SGD","LU2764263039.SGD","LU1181866309.USD","LU0069063385.USD","LU0302445910.USD","LU1201861249.SGD","LU0787776722.HKD","IE0002141913.USD","LU0395794307.EUR","SIBM0main","SPTE","LU2092937148.SGD","LU1400636657.SGD","LU0011850046.USD","LU2543165471.USD","BK4598","LU2286300806.USD","BK4516","IHE","IE0001KFT4U8.USD","LU1721428933.USD","DVY","LU1778281490.HKD","LU2242650005.HKD","IE00B3SWFQ91.USD","LU0057025933.USD","MSFW","BK4576","IE00BWXC8680.SGD","LU1496350171.SGD","LU1582986359.USD","LU1935043452.HKD","LU1868837136.USD","GB00BDT5M118.USD","LU0107464264.USD","LU1629891620.HKD","LU1883839398.USD","LU2360032135.SGD","SGXZ23171101.USD","LU0882574139.USD","LU1267930730.SGD","LU0690374961.EUR","LU1429558221.USD","LU2237957902.USD","LU2896262040.SGD","LU0320765059.SGD","LU0795875169.SGD","LU0267386448.USD","LU1718418525.SGD","LU0354030511.USD","MSFL","LU2023250843.SGD","TRUH","BK4579","LU0310800965.SGD","LU0994945656.USD","LU2360108059.USD","LU2999663052.SGD","MSFD","SG9999014914.USD","BK4608","LU2264538146.SGD","LU1914381329.SGD","LU0345770308.USD","LU2361044949.HKD","LU0683600562.USD","LU0965509101.SGD","LU1340139317.AUD","DOG","LU0210536198.USD","LU2279689827.SGD","LU1236620834.HKD","SG9999015358.SGD","LU0203345920.USD","LU0648000940.SGD","LU1823568750.SGD","LU0211327993.USD","LU0444973449.USD","CRMG","LU1548497426.USD","LU1989771016.USD","LU2471134523.USD","BK4602","BK4581","LU1720051108.HKD","LU0203202063.USD","LU1935042215.USD","LU2108987350.USD","LU2462591277.SGD",".DJI","BK4592","LU0432979614.USD","LU0820561909.HKD","BK4585","LU2028103732.USD","LU0347712357.USD","LU0795875086.SGD","LU1989764664.SGD","SG9999002224.SGD","LU1633808545.USD","IE00BDRTCR15.USD","LU1803068623.USD","LU2087621335.USD","SG9999001424.SGD","LU0109394709.USD","LU2083900584.USD","LU0149725797.USD","LU0130517989.USD","LU1221951129.SGD","MSFY","LU2210149790.SGD","LU0175139822.USD","LU0823421333.USD","LU1670710661.SGD","LU1261432733.SGD","SG9999001440.SGD","LU2430703095.HKD","VGT","SG9999000418.SGD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU1023059063.AUD","LU0234570918.USD","LU2237443978.SGD","LU2750360997.AUD","LU0157215616.USD","LU1585245621.USD","LU1868837300.USD","LU0170899867.USD","LU0894485498.HKD","LU2047632596.USD","LU1201861165.SGD","LU0215105999.USD","LU0320765992.SGD","LU0672654240.SGD","FTEC","LU0203347892.USD","LU0719512351.SGD","LU1267930573.SGD","SG9999014567.USD","IE00B3S45H60.SGD","LU0289941410.SGD","LU2129689605.HKD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU2552382215.SGD","MSFO","LU0980610538.SGD","LU1400636574.HKD","LU2065169927.USD","UDOW","BK4097","LU1923623000.USD","GDOC","LU1066051811.HKD","LU0949170772.SGD","IE00BDCRKT87.USD","LU1366192091.USD","LU0494093205.USD","LU2065170008.USD","MSFC","SG9999014542.SGD","LU2413666426.HKD","LU0124676726.USD","SCHD","DIA","SDY","LU1712237335.SGD","LU1202635105.USD","SG9999015986.USD","LU0345768153.USD","LU0320765646.SGD","LU1435385759.SGD","BK4505","HK0000532082.HKD","LU2023251221.USD","LU2125154778.USD","GB00B4LPDJ14.GBP","LU2244417387.USD","LU2413666699.HKD","LU0742534661.SGD","IE00BKDWB100.SGD","BK4559","LU2491050071.SGD","IE000ITXATA3.USD","SG9999014559.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU2491050154.USD","LU2326559502.SGD","LU0072462426.USD","IE00B775SV38.USD","LU0345774631.USD","BK4534","TBXU","LU1059921491.USD","LU0310799852.SGD","BK4612","LU0965508806.USD","LU2054465674.USD","LU1057294990.SGD","LU1983260115.SGD","LU0321505868.SGD","LU1791710400.SGD","TYLG","LU2089284900.SGD","SCHG","LU0080751232.USD","IE00BFSS7M15.SGD","LU2237443382.USD","LU2430703178.SGD","IE00BBT3K403.USD","GB00B4QBRK32.GBP","LU0109392836.USD","LU0545562505.USD","LU1951198990.SGD","BK4587","WQTM","LU0708995401.HKD","LU2242646821.SGD","LU2471134879.HKD","IE0003U64NQ7.SGD","LU0960925559.SGD","LU1989763005.USD","LU1935042991.SGD","LU0029864427.USD","IE00BVYPNW00.USD","IE00BJJMRX11.SGD","LU1564329628.SGD","IE0004445239.USD","LU2242649171.HKD","IE00B775H168.HKD","JNJ","LU0158827948.USD","LU0053666078.USD","LU0127658192.USD","LU1506573853.SGD","LU1366333091.USD","LU2097344431.USD","LU2756315318.SGD","LU1267930490.SGD","LU1316542783.SGD","LU1697837992.HKD","LU0154236417.USD","BK4504","LU1861127337.USD","SG9999018857.SGD","LU2065171311.SGD","LU1032466523.USD","IE00B4YYXB79.USD","LU0138981039.USD","LU1929549753.HKD","MSFT","LU2125154935.USD","LU0266013472.USD","SG9999001176.USD","IE00BQXX3C00.GBP","IE0009355771.USD","LU0444971666.USD","LU0985320562.USD","TTXU","LU0323240290.USD","LU1119994496.HKD","LU0316494557.USD","LU1935043023.USD","LU2211815571.USD","LU2433249047.HKD","RXL","LU0466842654.USD","LU2430703251.USD","IE00BGHQF631.EUR","LU1989772840.SGD","LU1400636491.USD","LU1720051017.SGD","LU2213496289.HKD","LU1582987324.SGD","LU0077335932.USD","LU1564329032.USD","SG9999014880.SGD","BK4550","LU2764263203.CNY","BK4566","IE00B1XK9C88.USD","LU1674673428.USD","LU1232071149.USD","LU1291159041.SGD","LU2463028550.USD","04332","LU0788109477.HKD","LU2275660780.HKD","SGXZ81514606.USD","LU1267930227.SGD","LU0861579265.USD","LU1221951046.USD","LU2347655156.SGD","LU1084165304.USD","LU1334329650.SGD","LU1564329461.SGD","IBBQ","LU2452424414.USD","LU1934455277.USD","LU1244550221.USD","VYMI","LU0345769631.USD","BK4568","SG9999015952.SGD","LU2111349929.HKD","LU2298321311.HKD","LU0314106906.USD","LU2506952097.USD","LU1061106388.HKD","LU0708994859.HKD","LU0871640123.AUD","IE00BFXG0V08.USD","LU0162691827.USD","LU2458330243.SGD","LU2237443549.SGD","SGXZ57979304.SGD","LU0345774391.USD","LU1935042488.USD","HK0000914660.USD","LU0098860793.USD","LU0784385170.HKD","LU1852331112.SGD","LU2271345857.HKD","LU0476273544.USD","LU2112291526.USD","LU0052756011.USD","BK4543","LU0689472784.USD","LU3102509885.SGD","MSFX","LU0943347566.SGD","LU0784385840.USD","SG9999013999.USD","IE000KEQY171.SGD","LU2361045086.USD","LU0792757196.USD","BK4561","LU1145028129.USD","LU2347655073.USD","SGXZ31699556.SGD","SMSFTmain","LU0308772762.SGD","LU0320765489.SGD","IYH","GAMR","LU0323239441.USD","LU0894486033.HKD","LU1066051498.USD","LU0070302665.USD","LU2506952170.USD","LU0868494617.USD","SG9999014906.USD","DJX","LU0072461881.USD","LU0889565916.HKD","LU0289739699.SGD","LU1551013425.SGD","IE00BZ1G4Q59.USD","IE00B5TLWC47.USD","LU1691799644.USD","LU0289960550.SGD","LU2092937221.SGD","HK0000914686.HKD","LU2100268510.USD","SG9999017495.SGD","LU1670627923.USD","IE00BK4W5M84.HKD","VYM","YMAX","LU0211328371.USD","LU0130102774.USD","LU2505996681.GBP","IE000M9KFDE8.USD","LU2237443465.HKD","IE00BJJMRY28.SGD","LU0964807845.USD","FTXH","LU2746668974.SGD","LU2471134796.USD","LU1162221912.USD","LU1127390331.HKD","SG9999015945.SGD","MSFU","MGK","LU0133085943.USD","LU0949170426.SGD","LU0957808578.USD","LU1074936037.SGD","LU1989772923.USD","LU0477156797.USD","LU0390134368.USD","LU2592432038.USD","LU0058720904.USD","LU2125909593.SGD","LU0950375773.USD","IXN","LU2860962120.EUR","LU0345770993.USD","LU1732799900.SGD","LU1839511570.USD","LU0106261372.USD","LU2133065610.SGD","LU0882574055.USD","LU2023250504.SGD","LU2168564065.EUR","LU1989764748.USD","LU0477156953.USD","IE00BLSP4452.SGD","FDVV","LU2106854487.HKD","LU0096364046.USD","LU2265009873.SGD","IE0005OL40V9.USD","LU1917777945.USD","LU2764262908.HKD","IE00BN29S564.USD","LU0276348264.USD","LU0417517546.SGD","LU1670756490.USD","IE00BVYPNV92.GBP","LU1564329115.USD","LU0056508442.USD","LU0689626769.HKD","DJIA","DGRW","JDOC","LU0889565833.HKD","LU1880398471.USD","LU2637965513.SGD","LU0545039389.USD","LU0079474960.USD","LU1121112475.USD","LU1003077747.HKD","LU2237443895.HKD","LU0823417653.USD","SGXZ80539844.SGD","LU1066051225.USD","AMGN","LU0265550946.USD","IBB","BK4588","LU2552382058.USD","LU1815336760.USD","LU0310800379.SGD","LU0889566641.SGD","SKYY","IE000WAW04H5.SGD","BK4548","LU2247934214.USD","IE00B5949003.HKD","IE00B4R5TH58.HKD","LU0965509283.SGD","LU1116320901.HKD","LU2404859667.USD","PJP","LU0823434740.USD","IE000SO60NU8.SGD","TDIV","LU1496350502.SGD","GRNY","LU0095938881.EUR","IE00BSNM7G36.USD","LU0048584097.USD","LU0456855351.SGD","LU0203201768.USD","LU2210150020.SGD","LU1732800096.USD","LU2102340556.USD","LU1551013342.USD","LU1815333072.USD","TOPT","IE00BYXW3230.USD","BK4134","LU2065171402.SGD","LU1032955483.USD","LU1066053197.SGD","LU0323591593.USD","VHT","SG9999015341.SGD","LU0321505439.SGD","LU0348723411.USD","LU1244550577.SGD","SG9999018865.SGD","LU0251142724.SGD","LU2403377893.USD","LU0210533765.USD","BK4532","LU2089283258.USD","IGV","LU2360106780.USD","LU1894683264.USD","DDM","BK4613","LU0238689110.USD","IE00BMPRXN33.USD","IE00BFSS8Q28.SGD","LU0426417589.USD","IE00BJTD4V19.USD","BK4139","LU1623119135.USD","LU2129689514.USD","LU2505996509.AUD","LU0823434583.USD","IE000W1ABFV2.USD","LU2237957811.SGD","LU0859254822.USD","LU2168563687.JPY","LU2468319806.SGD","LU2191332357.HKD","LU0511384066.AUD","LU0823421416.USD","LU1280957306.USD","LU2362541273.HKD","LU2362541513.USD","LU0661504455.SGD","LU0234572021.USD","LU0256863811.USD","IE00B3PB1722.GBP","LU0345768740.USD","LU0738911758.USD","LU1228905540.USD","LU0225283273.USD","LU0726765562.USD","SG9999014898.SGD","IE000YTNTUN2.SGD","LU0171293334.USD","LU0265550359.USD","LU1804176565.USD","BK4023","BBH","LU2954938101.SGD","LU0082616367.USD","BIB","IE0009356076.USD","BK4528","BK4554","LU0426412945.USD","LU1571399168.USD","BK4575","LU0642271901.SGD","LU0557290698.USD","LU2362540622.SGD","LU2602419157.SGD","IE00B19Z9505.USD","LU0128525689.USD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327289","title":"Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327289","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327289?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:43","pubTimestamp":1788867829,"startTime":"0","endTime":"0","summary":"Johnson & Johnson Innovation names Silvia Chen head of JLABS ShanghaiJohnson & Johnson Innovation-JJDC appointed Silvia Chen as site head of JLABS Shanghai.Chen brings more than two decades in healthc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9xctQs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","VHT","LU1674673428.USD","IE00B3T34201.USD","LU0345770993.USD","LU0882574055.USD","LU2471134523.USD","LU2505996509.AUD","IE000SO60NU8.SGD","LU1244550577.SGD","TRUH","LU0820561909.HKD","IE0009355771.USD","LU1718418525.SGD","IE00B19Z3581.USD","LU2129689605.HKD","LU2089984988.USD","IXJ","LU2456880835.USD","LU2505996681.GBP","BK4504","LU1280957306.USD","LU1551013425.SGD","LU0203345920.USD","IE00BZ1G4Q59.USD","PJP","JDOC","FTXH","LU2471134952.CNY","LU1043141396.HKD","LU0210528500.USD","LU0426412945.USD","LU0689626769.HKD","LU1066051498.USD","BMED","LU0640476718.USD","JNJ","LU1066053197.SGD","RXL","GDOC","FHLC","LU0058720904.USD","LU0820562030.AUD","XLV","LU0432979614.USD","LU2750360641.GBP","IYH","LU1496350502.SGD","MEDX","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665473327","title":"Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2665473327","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665473327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:41","pubTimestamp":1788867677,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  said Tuesday that its CAR-T cell therapy arlocabtagene autoleucel met the primary and secondary endpoints of a phase 2 trial to treat adults with quadruple-class exposed relapsed and refractory multiple myeloma.The company said the study's results met its primary endpoint of demonstrating a statistically significant and clinically meaningful overall response rate in heavily pretreated adults with the blood cancer with at least four lines of therapy. It also said the study met key secondary endpoints, including a complete response rate in patients with at least three previous lines of therapy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1236620834.HKD","BMY","LU1291159041.SGD","LU0868494617.USD","LU1430594728.SGD","LU1868836914.USD","LU0985481810.HKD","LU0096364046.USD","BK4588","FTXH","LU0267386448.USD","LU1883839398.USD","LU0237698245.USD","LU2125154935.USD","BK4559","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4581","LU1236620750.USD","BK4585","LU1323610961.USD","LU2242652126.USD","LU0321505439.SGD","IE00B2B36J28.USD","LU1868836757.USD","LU0432979614.USD","LU1032466523.USD","LU1093756325.SGD","LU1718418525.SGD","LU0306806265.USD","BK4007","LU1868837300.USD","LU0882574055.USD","LU1585245621.USD","LU1868836591.USD","LU1571399168.USD","LU1670711040.USD","LU1074936037.SGD","IHE","LU0306807586.USD","LU1261432733.SGD","IE0002141913.USD","LU0225284248.USD","LU1868837136.USD","LU0225771236.USD","LU1670710588.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327821","title":"Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327821","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327821?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865885,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) announced positive Phase 2 results from the registrational QUINTESSENTIAL trial of arlocabtagene autoleucel in adult patients w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1291159041.SGD","LU1883839398.USD","BMY","LU0061475181.USD","LU0237698245.USD","BK4126","LU0225284248.USD","LU1032466523.USD","LU1718418525.SGD","BK4559","BK4585","LU1093756168.USD","LU1093756325.SGD","MYE","LU0456855351.SGD","LU1989771016.USD","LU0868494617.USD","LU1670711123.USD","PSIL","LU0985481810.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1236620834.HKD","LU2133065610.SGD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2596442595.SGD","BBC","LU1074936037.SGD","IE0009355771.USD","LU2360032135.SGD","FTXH","IHE","IE00BSNM7G36.USD","LU1236620750.USD","LU1430594728.SGD","LU1670710588.SGD","LU0432979614.USD","LU0882574055.USD","BK4534","LU2125154935.USD","LU0114720955.EUR","LU0267386448.USD","LU1868836914.USD","LU1670710661.SGD","LU1983299246.USD","BK4588","LU2242652126.USD","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832218","title":"Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832218?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865386,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb's therapy meets mid-stage trial goalSept 8 (Reuters)-Bristol Myers SquibbBMY.Nsaid on Tuesday its experimental cell therapy met the main goal of a mid-stage trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU2596442595.SGD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU0225284248.USD","LU0061475181.USD","BK4534","LU0985481810.HKD","LU1670710661.SGD","LU1093756168.USD","LU0432979614.USD","BK4588","LU0114720955.EUR","LU1883839398.USD","LU0306807586.USD","LU1236620750.USD","LU1718418525.SGD","LU1093756325.SGD","LU1868836914.USD","LU0237698245.USD","LU1989771016.USD","LU1430594728.SGD","LU1291159041.SGD","IHE","LU1868836591.USD","BK4585","IE0009355771.USD","IE00BSNM7G36.USD","LU1670711123.USD","LU1236620834.HKD","LU2242652126.USD","LU0882574055.USD","IE0002141913.USD","FTXH","LU0306806265.USD","LU2360032135.SGD","LU1670710588.SGD","LU0267386448.USD","LU0868494617.USD","LU1983299246.USD","LU0096364046.USD","BK4559","LU0456855351.SGD","BMY","LU1074936037.SGD","LU1032466523.USD","LU1261432733.SGD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU2125154935.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322873","title":"Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322873?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125154778.USD","BK4588","LU0306806265.USD","BK4581","LU2242646821.SGD","LU2596442595.SGD","LU1989771016.USD","LU0321505868.SGD","LU0096364046.USD","BMY","LU1323610961.USD","IHE","LU2242652126.USD","LU1670711040.USD","LU1868836591.USD","LU0432979614.USD","BK4534","LU1236620834.HKD","LU0321505439.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU0225284248.USD","FTXH","LU1074936037.SGD","LU2125154935.USD","LU1868837300.USD","LU1291159041.SGD","LU1261432733.SGD","LU1236620750.USD","LU1032466523.USD","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","LU1883839398.USD","LU0237698245.USD","LU1430594728.SGD","LU0985481810.HKD","LU0267386448.USD","IE0009355771.USD","LU2133065610.SGD","LU1093756325.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU0868494617.USD","LU1093756168.USD","IE0002141913.USD","LU1670710661.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322827","title":"Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322827?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BSNM7G36.USD","BK4532","LU2360032135.SGD","LU0432979614.USD","LU1670711123.USD","LU1585245621.USD","LU0985481810.HKD","LU0096364046.USD","BK4559","FTXH","LU0456855351.SGD","LU0225284248.USD","BK4581","LU2242646821.SGD","LU1989771016.USD","LU1571399168.USD","IE00BFXG1179.USD","LU0267386448.USD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU2242652126.USD","LU0306807586.USD","LU1236620834.HKD","LU0225771236.USD","LU0237698245.USD","IE0002141913.USD","LU1868837300.USD","BK4588","BK4534","BMY","LU1983299246.USD","LU0321505439.SGD","LU1868836591.USD","LU1868836914.USD","LU1074936037.SGD","LU1670711040.USD","IHE","LU0306806265.USD","BK4585","LU1236620750.USD","LU1323610961.USD","LU0882574055.USD","LU1093756168.USD","IE0009355771.USD","LU1032466523.USD","LU1291159041.SGD","LU2133065610.SGD","LU0061475181.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322824","title":"Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322824?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0114720955.EUR","LU2133065610.SGD","LU0267386448.USD","LU0868494617.USD","LU1983299246.USD","LU1868837300.USD","LU1323610961.USD","LU1074936037.SGD","LU2125154935.USD","LU0321505439.SGD","LU1868836914.USD","LU1670711123.USD","LU1868836757.USD","LU1430594728.SGD","IHE","LU0432979614.USD","BMY","LU0456855351.SGD","LU0306806265.USD","IE0009355771.USD","LU0882574055.USD","LU2242652126.USD","LU1718418525.SGD","IE00BJJMRZ35.SGD","LU1670710588.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1291159041.SGD","LU1868836591.USD","LU0096364046.USD","LU0237698245.USD","LU0306807586.USD","BK4007","LU0321505868.SGD","IE00B2B36J28.USD","LU0985481810.HKD","LU0225771236.USD","LU1236620834.HKD","LU1093756168.USD","LU0061475181.USD","LU2125154778.USD","LU1236620750.USD","LU1670711040.USD","FTXH","IE0002141913.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","BK4532","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665242473","title":"Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665242473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665242473?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864348,"startTime":"0","endTime":"0","summary":"Merck CEO Davis, R&D head Li to speak at Morgan Stanley Global Healthcare ConferenceMerck will join Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.CEO Robert M. Davis will","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL445tZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051225.USD","LU1037948541.HKD","LU0868494617.USD","IE00BJT1NW94.SGD","TRUH","LU1093756325.SGD","LU2491049909.HKD","LU1571399168.USD","LU1934455194.USD","LU2125909593.SGD","LU2125154778.USD","LU2361044949.HKD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU1162221912.USD","LU2357627491.SGD","LU1934455277.USD","LU0238689110.USD","BK4007","LU1057294990.SGD","LU0211331839.USD","LU1917777945.USD","LU1699723380.USD","LU0266013472.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","LU0868494708.USD","LU2491050154.USD","JDOC","LU0124676726.USD","LU1941712264.USD","RXL","IE00B4R5TH58.HKD","LU0122379950.USD","LU1066051498.USD","LU1061106388.HKD","HRTS","LU0320765646.SGD","LU1035773651.USD","LU0859254822.USD","SG9999002224.SGD","PPH","SG9999001176.USD","IE0009355771.USD","SG9999002232.USD","SG9999001176.SGD","LU1974910355.USD","SG9999014542.SGD","BK4534","SG9999014575.USD","LU1116320901.HKD","LU1066051811.HKD","SG9999015358.SGD","LU0070302665.USD","LU0106261372.USD","LU0234572021.USD","LU2125154935.USD","LU0965509101.SGD","LU2433249047.HKD","VHT","LU0432979614.USD","LU0861579265.USD","IE00BSNM7G36.USD","GDOC","LU1032466523.USD","LU1934455863.HKD","FHLC","LU2023250504.SGD","BK4559","BK4516","SGXZ57979304.SGD","IE00BLSP4239.USD","LU2461242641.AUD","LU2112291526.USD","LU2023250843.SGD","LU2089984988.USD","FTXH","LU2106854487.HKD","LU1585245621.USD","IE00B1BXHZ80.USD","LU0265550359.USD","BK4585","IE00BLSP4452.SGD","LU1023059063.AUD","LU1201861249.SGD","LU0130102774.USD","LU0320765489.SGD","LU0006306889.USD","LU2361044865.SGD","LU0965509010.AUD","LU0265550946.USD","SG9999015341.SGD","BMED","LU2324357040.USD","LU1929549753.HKD","IYH","LU2468319806.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4533","XLV","LU0058720904.USD","LU0098860793.USD","SG9999014567.USD","LU1291159041.SGD","IE000M9KFDE8.USD","BK4550","SG9999014559.SGD","LU0203345920.USD","LU0823416689.USD","LU1430594728.SGD","LU0965508806.USD","LU0980610538.SGD","LU0965509283.SGD","LU0689626769.HKD","LU2360032135.SGD","LU1066053197.SGD","LU2361045086.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU1116320737.USD","PAWZ","SG9999013999.USD","LU1923622614.USD","LU2491050071.SGD","SG9999001440.SGD","LU1093756168.USD","LU1037948897.HKD","LU0208291251.USD","LU0648001328.SGD","IE0002141913.USD","IE00BBT3K403.USD","LU1989772923.USD","LU0942090050.USD","LU0477156953.USD","LU1069347547.HKD","LU1941712348.USD","LU2125909247.SGD","IXJ","LU0130517989.USD","MRK","BK4588","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324477","title":"Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324477","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324477?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:42","pubTimestamp":1788864129,"startTime":"0","endTime":"0","summary":"Merck & Co. (MRK) has an average rating of overweight and mean price target of $149.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BSNM7G36.USD","LU1934455277.USD","HRTS","LU2360032135.SGD","LU0432979614.USD","LU2112291526.USD","LU1066051811.HKD","BK4559","LU0106261372.USD","LU0859254822.USD","LU0203347892.USD","LU1571399168.USD","MRK","LU0965509101.SGD","SG9999014559.SGD","LU0942090050.USD","VHT","PAWZ","SGXZ57979304.SGD","PPH","SG9999001440.SGD","BK4550","LU2125909247.SGD","LU1093756168.USD","LU2357627491.SGD","LU1116320901.HKD","LU0289739699.SGD","JDOC","LU2125909593.SGD","LU2491050154.USD","LU0208291251.USD","LU0985320562.USD","LU1699723380.USD","IE00BJT1NW94.SGD","BK4516","LU1923622614.USD","LU1023059063.AUD","LU0006306889.USD","FTXH","LU1989771016.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","IYH","LU2461242641.AUD","LU2491050071.SGD","LU0648001328.SGD","LU1093756325.SGD","SG9999001176.USD","LU0965509283.SGD","GDOC","BMED","SG9999002224.SGD","LU0211331839.USD","LU1983299246.USD","LU0058720904.USD","IE00B2B36J28.USD","SG9999015341.SGD","LU0320765646.SGD","LU0823416689.USD","LU0965509010.AUD","IE00BN8TJ469.HKD","LU1934455194.USD","LU1934455863.HKD","IE0009355771.USD","LU1035773651.USD","LU2433249047.HKD","LU2468319806.SGD","XLV","LU1291159041.SGD","IE00B1BXHZ80.USD","LU1941712348.USD","LU2491049909.HKD","LU1162221912.USD","LU1989772923.USD","LU1066051225.USD","LU2023250843.SGD","LU1585245621.USD","BK4007","SG9999014567.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","IE000M9KFDE8.USD","LU0234572021.USD","IE00BBT3K403.USD","LU0098860793.USD","LU2089984988.USD","SG9999001176.SGD","LU1430594728.SGD","BK4588","LU0130102774.USD","SG9999002232.USD","LU1066053197.SGD","IXJ","LU0130517989.USD","TRUH","LU2361044865.SGD","IHE","LU0689626769.HKD","LU1116320737.USD","LU2324357040.USD","LU0868494617.USD","RXL","BK4533","LU0980610538.SGD","LU0122379950.USD","LU1974910355.USD","LU1989772840.SGD","LU2125154935.USD","LU0070302665.USD","LU1201861249.SGD","SG9999014575.USD","LU2361044949.HKD","SG9999013999.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU0265550946.USD","LU1069347547.HKD","LU1057294990.SGD","LU0238689110.USD","LU2125154778.USD","LU1037948897.HKD","LU1037948541.HKD","LU0320765489.SGD","LU0477156953.USD","LU0868494708.USD","IE0002141913.USD","LU0124676726.USD","BK4534","LU2106854487.HKD","FHLC","LU2361045086.USD","BK4585","LU0266013472.USD","SG9999015358.SGD","LU1929549753.HKD","LU2023250504.SGD","LU0861579265.USD","SG9999014542.SGD","LU1061106388.HKD","LU0203345920.USD","LU1066051498.USD","IE00B4R5TH58.HKD","LU1032466523.USD","IE00BLSP4239.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665281321","title":"Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146","url":"https://stock-news.laohu8.com/highlight/detail?id=2665281321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665281321?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:15","pubTimestamp":1788862514,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0098860793.USD","JDOC","LU1699723380.USD","LU1941712348.USD","LU2491049909.HKD","LU0106261372.USD","RXL","SG9999013999.USD","LU0689626769.HKD","BK4533","LU1571399168.USD","LU0980610538.SGD","XLV","LU0868494708.USD","LU0070302665.USD","LU0234572021.USD","LU2324357040.USD","LU0208291251.USD","BK4588","SG9999002224.SGD","LU0861579265.USD","LU1037948541.HKD","SG9999015358.SGD","BK4516","IE000M9KFDE8.USD","SG9999002232.USD","BK4534","LU0320765646.SGD","IE00BJT1NW94.SGD","FHLC","LU2125909593.SGD","FTXH","LU2023250504.SGD","LU0124676726.USD","LU0130517989.USD","LU0238689110.USD","LU1093756325.SGD","LU1057294990.SGD","LU1989771016.USD","LU2125909247.SGD","LU2089984988.USD","LU1116320737.USD","LU0432979614.USD","LU0211331839.USD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU1974910355.USD","LU1934455863.HKD","LU1989772840.SGD","LU1066051811.HKD","IE00BLSP4452.SGD","LU0985320562.USD","LU1291159041.SGD","SG9999015341.SGD","SGXZ57979304.SGD","LU2433249047.HKD","LU0965509101.SGD","SG9999014567.USD","LU1037948897.HKD","LU1929549753.HKD","LU0868494617.USD","BMED","LU0289739699.SGD","LU2023250843.SGD","LU2361044949.HKD","LU2106854487.HKD","IE00B1BXHZ80.USD","GDOC","LU1035773651.USD","SG9999001176.USD","LU2360032135.SGD","LU1923622614.USD","LU0965509010.AUD","LU1941712264.USD","MRK","PAWZ","LU1989772923.USD","PPH","LU1934455194.USD","LU0965508806.USD","IXJ","LU2491050071.SGD","LU2125154778.USD","SG9999001440.SGD","LU0006306889.USD","LU1032466523.USD","IE00BLSP4239.USD","LU1917777945.USD","SG9999014559.SGD","VHT","LU2361045086.USD","IE00B4R5TH58.HKD","TRUH","LU0265550359.USD","LU0320765489.SGD","LU0265550946.USD","SG9999001176.SGD","IHE","BK4007","SG9999014575.USD","LU1201861249.SGD","LU1430594728.SGD","HRTS","LU0965509283.SGD","LU0130102774.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU0477156953.USD","LU0823416689.USD","LU0122379950.USD","LU1061106388.HKD","BK4550","LU0058720904.USD","LU0203347892.USD","LU0648001328.SGD","LU1066053197.SGD","IE0009355771.USD","LU2357627491.SGD","LU0266013472.USD","IE00BSNM7G36.USD","LU2125154935.USD","IE0002141913.USD","LU2491050154.USD","BK4559","LU0203345920.USD","LU1066051225.USD","LU1983299246.USD","LU2361044865.SGD","LU1023059063.AUD","LU0859254822.USD","LU1585245621.USD","LU1066051498.USD","LU1162221912.USD","LU1934455277.USD","LU2461242641.AUD","BK4585","LU1093756168.USD","SG9999014542.SGD","LU1069347547.HKD","LU2112291526.USD","LU0942090050.USD","IE00BN8TJ469.HKD","LU1116320901.HKD","IYH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232106","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232106?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1929549753.HKD","IXJ","LU0128525929.USD","PJP","LU0861579265.USD","FHLC","IYH","LU0859254822.USD","LU1291159041.SGD","IE00B3PB1722.GBP","AGNG","FTXH","BK4550","LU0965509010.AUD","RXL","BK4137","HCSG","IE00BVYPNV92.GBP","MEDX","LU1551013342.USD","LU0211328371.USD","SMMT","JDOC","LU0211327993.USD","XBI","LU1037948897.HKD","ABBV","LU0553294199.USD","LU2237443549.SGD","VHT","TRUH","LU0417517546.SGD","IE0004445239.USD","LU0029874061.USD","LU2433249047.HKD","RPRX","LABU","IE000BZT7R73.USD","LU1057294990.SGD","PPH","LU1244550494.USD","LU1003077747.HKD","GLAM","IHE","XLV","LU0823416689.USD","LU0689626769.HKD","LU2347655073.USD","PBE","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326063","title":"Jeito Capital Promotes Pascal Touchon to Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326063","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326063?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:31","pubTimestamp":1788859918,"startTime":"0","endTime":"0","summary":"Jeito Capital promotes Pascal Touchon to partnerJeito Capital promoted Pascal Touchon to partner; he previously served as CEO of Atara Biotherapeutics from 2019 to 2024.Claudio Costa-Neto was promoted","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL6fX32t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2596442595.SGD","LU1236620750.USD","LU1868836914.USD","LU1670710588.SGD","LU1670711040.USD","BK4588","LU0114720955.EUR","LU1323610961.USD","LU2242652126.USD","LU2360032135.SGD","BK4585","IE0002141913.USD","BK4532","LU0985481810.HKD","LU2242646821.SGD","BMY","LU0882574055.USD","LU0321505868.SGD","LU0432979614.USD","IE00BFXG1179.USD","FTXH","LU0225284248.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IHE","LU1291159041.SGD","LU0321505439.SGD","LU1670710661.SGD","LU1868837300.USD","LU1585245621.USD","LU0868494617.USD","BK4559","LU1571399168.USD","LU0096364046.USD","LU2125154935.USD","LU1670711123.USD","ATRA","LU0456855351.SGD","BK4534","LU0237698245.USD","LU0306806265.USD","LU1093756168.USD","LU1883839398.USD","LU1261432733.SGD","LU1236620834.HKD","BK4581","LU0225771236.USD","BK4007","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332552","title":"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332552?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:30","pubTimestamp":1788856210,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Sanofi (SNYNF) and Merck & Company (MRK) with neutral ratings, indicating that the experts are neithe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU0122379950.USD","LU0124676726.USD","LU0203347892.USD","IXJ","LU0432979614.USD","IHE","LU1989772840.SGD","LU1066051498.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999014575.USD","LU1941712264.USD","LU0868494708.USD","LU1699723380.USD","IE00BLSP4239.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0868494617.USD","LU2360032135.SGD","LU0689626769.HKD","PAWZ","LU1057294990.SGD","IE00BLSP4452.SGD","LU1093756168.USD","BK4588","LU0320765489.SGD","LU1116320737.USD","LU0823416689.USD","LU2361044865.SGD","GDOC","LU1941712348.USD","LU1066051811.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU2491050154.USD","PPH","LU0208291251.USD","LU1035773651.USD","LU2125154778.USD","LU2125909247.SGD","SNYNF","LU1037948541.HKD","FTXH","LU2112291526.USD","BK4533","LU2361045086.USD","IE00B4R5TH58.HKD","LU1032466523.USD","SG9999013999.USD","SG9999001176.SGD","IE00BJT1NW94.SGD","IYH","LU1585245621.USD","SGXZ57979304.SGD","VHT","LU2023250843.SGD","LU2491050071.SGD","LU0006306889.USD","LU2106854487.HKD","FHLC","SG9999014567.USD","LU1291159041.SGD","LU0648001328.SGD","LU1983299246.USD","SG9999015358.SGD","IE00BSNM7G36.USD","IE00BN8TJ469.HKD","LU1934455194.USD","LU0965509010.AUD","BK4550","BK4007","LU0130517989.USD","JDOC","LU0266013472.USD","LU1989772923.USD","LU0965508806.USD","LU1989771016.USD","HRTS","LU2433249047.HKD","LU1934455863.HKD","LU1571399168.USD","LU1917777945.USD","BK4585","IE0009355771.USD","LU0265550359.USD","LU1934455277.USD","LU1066053197.SGD","SG9999014542.SGD","LU0859254822.USD","LU1430594728.SGD","LU0130102774.USD","LU1061106388.HKD","LU1201861249.SGD","LU2361044949.HKD","LU1974910355.USD","LU2357627491.SGD","BMED","LU0320765646.SGD","MRK","LU1066051225.USD","LU0942090050.USD","LU0965509101.SGD","SG9999001440.SGD","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","LU0861579265.USD","LU0211331839.USD","BK4516","LU2461242641.AUD","LU1093756325.SGD","TRUH","LU2491049909.HKD","BK4534","LU0965509283.SGD","LU2324357040.USD","LU0098860793.USD","LU1923622614.USD","LU2125909593.SGD","LU1929549753.HKD","LU2125154935.USD","LU0058720904.USD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0238689110.USD","LU1116320901.HKD","SG9999015341.SGD","LU0234572021.USD","LU0070302665.USD","LU0980610538.SGD","SG9999014559.SGD","LU1069347547.HKD","LU0265550946.USD","LU0477156953.USD","LU0985320562.USD","LU1162221912.USD","SG9999001176.USD","LU2023250504.SGD","BK4559","RXL","LU2089984988.USD","IE00BBT3K403.USD","LU0203345920.USD","LU0289739699.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}